Amanote Research
Register
Sign In
PWE-070 the Duodenal-Jejunal Bypass Sleeve (Endobarrier Gastrointestinal Liner) for Weight Loss and Treatment of Type Ii Diabetes
Gut
- United Kingdom
doi 10.1136/gutjnl-2013-304907.359
Full Text
Open PDF
Abstract
Available in
full text
Categories
Gastroenterology
Date
June 1, 2013
Authors
S Patel
D Hakim
J Mason
N Hakim
Publisher
BMJ
Related search
Effect of the EndoBarrier Gastrointestinal Liner on Obesity and Type 2 Diabetes: Protocol for Systematic Review and Meta-Analysis of Clinical Studies
BMJ Open
Medicine
Gastric Bypass vs Sleeve Gastrectomy for Type 2 Diabetes Mellitus
Archives of Surgery
Is Weight Loss the Future of Type 2 Diabetes Treatment?
Prescriber
Pharmacology
Laparoscopic Sleeve Gastrectomy: Perioperative Outcomes, Weight Loss and Impact on Type 2 Diabetes Mellitus Over 2 Years
Canadian Journal of Surgery
Medicine
Surgery
Improved FGF21 Sensitivity and Restored FGF21 Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats After Duodenal-Jejunal Bypass and Sleeve Gastrectomy
Frontiers in Endocrinology
Endocrinology
Metabolism
Diabetes
VLCD for Weight Loss and Remission of Type 2 Diabetes? – Authors' Reply
The Lancet
Medicine
Duodenal-Jejunal Bypass Protects GK Rats From -Cell Loss and Aggravation of Hyperglycemia and Increases Enteroendocrine Cells Coexpressing GIP and GLP-1
American Journal of Physiology - Endocrinology and Metabolism
Endocrinology
Physiology
Metabolism
Diabetes
Implications of Type II Diabetes Mellitus on Gastrointestinal Cancers
Letter: Non-Alcoholic Steatohepatitis and Type 2 Diabetes Mellitus: The Effects of Weight Loss Versus Drug Treatment
Current Medical Research and Opinion
Medicine
